These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11758536)

  • 21. Kinetic analysis of the inhibition of matrix metalloproteinases: lessons from the study of tissue inhibitors of metalloproteinases.
    Willenbrock F; Thomas DA; Amour A
    Methods Mol Biol; 2010; 622():435-50. PubMed ID: 20135297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
    Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
    J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis.
    Tervahartiala T; Pirilä E; Ceponis A; Maisi P; Salo T; Tuter G; Kallio P; Törnwall J; Srinivas R; Konttinen YT; Sorsa T
    J Dent Res; 2000 Dec; 79(12):1969-77. PubMed ID: 11201047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
    Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
    J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
    Impola U; Jeskanen L; Ravanti L; Syrjänen S; Baldursson B; Kähäri VM; Saarialho-Kere U
    Br J Dermatol; 2005 Apr; 152(4):720-6. PubMed ID: 15840104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma.
    Wiegand S; Dünne AA; Müller HH; Mandic R; Barth P; Davis RK; Werner JA
    Cancer; 2005 Jul; 104(1):94-100. PubMed ID: 15912516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
    Rosell A; Alvarez-Sabín J; Arenillas JF; Rovira A; Delgado P; Fernández-Cadenas I; Penalba A; Molina CA; Montaner J
    Stroke; 2005 Jul; 36(7):1415-20. PubMed ID: 15947272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14.
    Filanti C; Dickson GR; Di Martino D; Ulivi V; Sanguineti C; Romano P; Palermo C; Manduca P
    J Bone Miner Res; 2000 Nov; 15(11):2154-68. PubMed ID: 11092396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases.
    Ljumovic D; Diamantis I; Alegakis AK; Kouroumalis EA
    Clin Chim Acta; 2004 Nov; 349(1-2):203-11. PubMed ID: 15469875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix-metalloproteinases in Hodgkin lymphoma.
    Thorns C; Bernd HW; Hatton D; Merz H; Feller AC; Lange K
    Anticancer Res; 2003; 23(2B):1555-8. PubMed ID: 12820423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
    Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
    Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
    Thorns V; Walter GF; Thorns C
    Anticancer Res; 2003; 23(5A):3937-44. PubMed ID: 14666700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes.
    Sadowski T; Steinmeyer J
    Osteoarthritis Cartilage; 2001 Jul; 9(5):407-15. PubMed ID: 11467888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effects of 1alpha,25-dihydroxyvitamin D3 in regulation matrix metalloproteinase and tissue metalloproteinase inhibitors in human osteoblasts].
    Guo LJ; Luo XH; Xie H; Zhou HD; Liao EY
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):125-8. PubMed ID: 15840226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
    Kolkenbrock H; Essers L; Ulbrich N; Will H
    Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of membrane type 1-matrix metalloproteinase and gelatinase A in head and neck squamous cell carcinoma invasion in vitro.
    Rosenthal EL; Hotary K; Bradford C; Weiss SJ
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):337-43. PubMed ID: 10504584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.